Cargando…
Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma
Renal cell carcinoma (RCC) is one of the most common malignant tumors with a poor response to radiotherapy and chemotherapy. The advent of molecular targeted drugs has initiated great breakthroughs in the treatment of RCC. However, drug resistance to targeted drugs has become an urgent problem. Vari...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686082/ https://www.ncbi.nlm.nih.gov/pubmed/36424596 http://dx.doi.org/10.1186/s12935-022-02790-w |